Non-PVC IV Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Non-PVC IV Bags Market is expected to register a CAGR of 5.5% during the forecast period. This is attributing to increasing natality rate, environment-friendly nature of Non-PVC IV bags, increasing government initiatives. In addition, increasing demand for innovative IV containers and growing awareness about preventive measures associated with conventional PVC IV bags. Non-PVC IV bags helps in minimizing the risk associated with conventional IV bags such as difficulty in transportation, the interaction of drugs and packaging material, disposable containers. These problems can be solved by adopting Non-PVC IV Bags.

Moreover, the material used in these bags is polypropylene and ethylene-vinyl acetate. In addition, there is increasing demand in oncology procedure treatment mainly in chemotherapy and targeted drug delivery as earlier agents which were used in therapies are interacting with the conventional PVC and forming harmful agents but by adopting these Non-PVC IV bags these problems are resolving and leading to promote the growth of the overall market. Furthermore, technological advancements in providing quality of services and a rising number of hospitals around the globe are few more factors driving the growth of the Non-PVC IV bags market.

Key Market Trends

By Material, Ethylene Vinyl Acetate (EVA) in Non-PVC IV Bags Market is Estimated to Witness a Healthy Growth in Future.

Ethylene Vinyl Acetate (EVA) is estimated to witness healthy growth in the future attributed to increasing usage in blood banks and the storage of frozen mixture. Moreover, growing awareness and increasing demand for blood and blood component storage due to the rising number of blood banks around the globe may boost segment growth.

The Copolyester ether segment is also going to show a lucrative opportunity in the forecasted period owing to several benefits associated with this such as chemical resistance, durability, clarity, and ability to withstand many sterilization processes.

In Addition, Single Chamber Non-PVC IV bags is expected to witness a slightly high market share due to its growing demand because of several advantages associated with this such as convenience in transportation, handling, and disposable. The growing number of hospital admissions with an increasing number of points of care facilities and home care settings is also fueling the growth of the overall market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Non-PVC IV Bags Market due to rising government initiatives, increasing stringency of regulatory bodies towards patient care and safety, growing research and development expenditure, rising prevalence of diseases like cancers and diarrhea, established healthcare infrastructure and presence of several major players. The United States owns the largest share of Non-PVC IV Bags Market in the North America region Furthermore, increasing adoption of novel drug delivery systems and technological advancements are also expected to fuel the Non-PVC IV Bags Market in this region.

Competitive Landscape

The Non-PVC IV Bags Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are B. Braun Medical Inc., Baxter, JW Life Science, RENOLIT SE, Fresenius Kabi, Shanghai Xin Gen Eco-Technologies Co., Ltd, Polycine GmbH, KRATON CORPORATION, and Angiplast Pvt. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support